Written By Shweta Ganjoo
Published By: Shweta Ganjoo | Published: Jan 30, 2024, 06:26 PM (IST)
Elon Musk’s neurotechnology company called Neuralink has successfully completed its first human implant. Musk, via a series of posts on X (formerly Twitter), said that the first human who received an implant from Neuralink is recovering well and that initial tests show promising neuron spike detection. Also Read: Cloudflare Outage Takes Down X (Twitter), ChatGPT, Canva, AWS And Valorant Worldwide: Here's What Happened
Musk also said Neuralink’s first product is called Telepathy and that it would enable users to control a smartphone, a laptop or any other electronic device simply by thinking about it. “Enables control of your phone or computer, and through them almost any device, just by thinking,” he wrote in his post. Also Read: Elon Musk’s X Rolls Out New ‘Chat’ Feature With End-to-End Encryption And Disappearing Messages
In the same post, Musk, who also owns X, Tesla and The Boring Company, said that the initial recipents of the brain implant, or Telepathy, would be people who have lost the use of their limbs. “Imagine if Stephen Hawking could communicate faster than a speed typist or auctioneer. That is the goal,” he added in his post. Also Read: GTA Online Goes Free On PS5 And Xbox After GTA 6 Delay: How To Claim
Enables control of your phone or computer, and through them almost any device, just by thinking.
Initial users will be those who have lost the use of their limbs.
Imagine if Stephen Hawking could communicate faster than a speed typist or auctioneer. That is the goal.
— Elon Musk (@elonmusk) January 30, 2024
It is worth noting that Neuralink received its FDA approval for conducting its first-in-human clinical trial in May 2023. It received $280 million of Series D funding by Peter Thiel’s Founder Fund in August 2023, following which it started recruiting people for its clinical trial.
While the initial aim of company is to use the brain implant for treating people with critical brain diseases and curing a host of conditions such as obesity, autism, depression and schizophrenia, the long-term aim is to use this technology for cognitive enhancement. At the moment, the company is deploying people for its clinical trial or what the company describes as ‘PRIME study’ that aims to help people with quadriplegia, cervical spinal cord injury or amyotrophic lateral sclerosis (ALS) to control external devices with their thoughts.
“This study involves placing a small, cosmetically invisible implant in a part of the brain that plans movements. The device is designed to interpret a person’s neural activity, so they can operate a computer or smartphone by simply intending to move – no wires or physical movement are required,” Neuralink’s website says.
Check out our latest video to learn more about our PRIME Study! 🧠📱 pic.twitter.com/7zTMFzdZsF
— Neuralink (@neuralink) November 22, 2023
Interestingly, Neuralink has not only developed a brain implant, but it has also developed a sewing machine-like device that is capable of implanting ultra-thin threads inside the brain. These threads connect to a custom-designed chip with electrodes that can read data from groups of neurons.